KOD Q1 2026 Earnings EPS Beat Despite No Revenue Stock Slips SHFS Q3 2024 Earnings Profitability Achieved Despite Limited Disclosure Monopar Therapeutics Q1 2026 Earnings Narrower Loss Surprises Market EQBK Q1 2026 Earnings EPS Misses Estimates by 3196 as Stock Edges Higher DOCS Q1 2026 Earnings Mixed Results as EPS Misses Estimates but Stock Rises RHP Q1 2026 Earnings Strong EPS Beat Drives Positive Surprise but Stock Slips 08